[COVID-19 in Latin America: a systematic review and bibliometric analysis]. / COVID-19 en Latinoamérica: una revisión sistemática de la literatura y análisis bibliométrico.
Rev Salud Publica (Bogota)
; 22(2): 246-252, 2020 03 01.
Article
em Es
| MEDLINE
| ID: mdl-36753116
ABSTRACT
OBJECTIVE:
Describe and analyze scientific activity on COVID-19 in Latin America. MATERIALS ANDMETHODS:
Through a systematic review of the literature in PubMed, LILACS, and the preprinted repositories BioRxiv and medRxiv, all available documents on COVID-19 in Latin America from January 1 to April 24, 2020, were retrieved for review and bibliometric analysis.RESULTS:
A total of 29 publications were included in the analysis. The country with the most scientific production was Brazil (10/29; 34,4%) followed by Colombia (6/29; 20,6%) and Mexico (6/29; 20,6%). The university with the most articles was the Technological University of Pereira, Colombia (5/29; 17,2%). 41,3% of the publications were preprinted documents. Most of the excluded studies were editorial comments or expert opinions. Three out of four investigations had an epidemiological focus (21/29; 72,4%); Limited studies on diagnosis (5/29; 17,24%), pathophysiology (2/29, 2,8%) and therapeutic.CONCLUSION:
Despite the exponential growth of publications in the world, there is a limited amount of information on the behavior of this infection in Latin America. The publication of studies with high methodological quality is required, which provide knowledge of the impact of the pandemic in the region.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
COVID-19
Tipo de estudo:
Systematic_reviews
Limite:
Humans
País/Região como assunto:
Mexico
Idioma:
Es
Revista:
Rev Salud Publica (Bogota)
Assunto da revista:
SAUDE PUBLICA
Ano de publicação:
2020
Tipo de documento:
Article